Reduced diabetic retinopathy severity can enhance functional vision

BOSTON — Ranibizumab treatment for diabetic retinopathy, with or without diabetic macular edema, may regress the severity of the retinopathy to a milder stage, thus enhancing other visual function outcomes, Jeffrey R. Willis, MD, PhD, said in a study presented at the American Society of Retina Specialists meeting.Adult patients with proliferative or nonproliferative diabetic retinopathy report significant functional and visual function difficulties, but treatment with Lucentis (Genentech) has been shown to reduce diabetic retinopathy by two steps or greater at 1-year follow-up, Willis said.

Full Story →